Optimal Sequence and Second-Line Systemic Treatment of Patients with <i>RAS</i> Wild-Type Metastatic Colorectal Cancer: A Meta-Analysis
Although several sequential therapy options are available for treating patients with <i>RAS</i> wild-type (WT) metastatic colorectal cancer (mCRC), the optimal sequence of these therapies is not well established. A systematic review and meta-analysis of 13 randomized controlled trials an...
Guardado en:
Autores principales: | Chih-Chien Wu, Chao-Wen Hsu, Meng-Che Hsieh, Jui-Ho Wang, Min-Chi Chang, Ching-Shiang Yang, Yi-Chia Su |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a3f36fd933aa44d89a5634388ced8c3f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Skin Toxicity as Predictor of Survival in Refractory Patients with <i>RAS</i> Wild-Type Metastatic Colorectal Cancer Treated with Cetuximab and Avelumab (CAVE) as Rechallenge Strategy
por: Davide Ciardiello, et al.
Publicado: (2021) -
Modern perspectives in sequential therapy for metastatic colorectal cancer with reference to the use of regorafenib
por: M. I. Sekacheva, et al.
Publicado: (2020) -
Hand-Assisted Laparoscopic Surgery Is Superior to Open Liver Resection for Colorectal Liver Metastases in the Posterosuperior Segments
por: Omar Abu-Zaydeh, et al.
Publicado: (2021) -
Clinical Translation of Combined MAPK and Autophagy Inhibition in <i>RAS</i> Mutant Cancer
por: Jennifer J. Lee, et al.
Publicado: (2021) -
Metastatic breast cancer: Endocrine therapy landscape reshaped
por: Mohamad Adham Salkeni, et al.
Publicado: (2017)